Strix
26.1K

CVE-2023-34333

HIGHCVSS 7.8/10EPSS 0.18%

Last modified

CVE-2023-34333 is a high-severity vulnerability rated 7.8/10 on the CVSS scale. AMI’s SPx contains a vulnerability in the BMC where an Attacker may cause an untrusted pointer to dereference via a local network. A successful exploitation of this vulnerability may lead to a loss of confidentiality, integrity, and/or availability. . EPSS estimates a 0.18% chance of exploitation in the next 30 days.

Description

AMI’s SPx contains a vulnerability in the BMC where an Attacker may cause an untrusted pointer to dereference via a local network. A successful exploitation of this vulnerability may lead to a loss of confidentiality, integrity, and/or availability.

Metrics

CVSS 3.1
7.8/10

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
0.18%

7.5th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
AmiMegarac Sp-X>= 12, < 12.7
AmiMegarac Sp-X>= 13, < 13.6

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2023-34333?
AMI’s SPx contains a vulnerability in the BMC where an Attacker may cause an untrusted pointer to dereference via a local network. A successful exploitation of this vulnerability may lead to a loss of confidentiality, integrity, and/or availability.
How severe is CVE-2023-34333?
CVE-2023-34333 has a CVSS score of 7.8/10 (HIGH severity). The EPSS model estimates a 0.18% probability of exploitation in the next 30 days.
How do I fix CVE-2023-34333?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-34333?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST